Results 241 to 250 of about 260,806 (301)

Effects of Lycium barbarum Residue Substituting Dietary Maize on Fecal Microbiota and Growth Performance of Crossbred Simmental Cattle

Animal Research and One Health, EarlyView.
The bioactive substances we extracted from Lycium barbarum residue (LBR) have a typical polysaccharide structure. When 1.80% LBR was used to replace maize in the diet, the average daily gain of rossbred Simmental was significantly increased, and anti‐inflammatory ability was improved. In addition, LBR improved the fecal microbial composition, increased
Kun Cai, Mingtan Li, Lihang He, Ning Ma, Haoyu Liu, Chi Xu, Xianhua Wu, Zeguang Xing, Qian Xing, Yuankai Qu, Xi Ma   +10 more
wiley   +1 more source

Correction: New insights into the mechanisms of electroconvulsive therapy in treatment-resistant depression. [PDF]

Front Psychiatry
Ruiz AC, Haseeb A, Baumgartner W, Leung E, Scaini G, Quevedo J.   +5 more
europepmc   +1 more source

Evaluation of Current Evidence on the Efficacy of Esketamine in Treating Substance-Use Disorders in Patients With Treatment-Resistant Depression (TRD): A Narrative Review. [PDF]

Cureus
Shelke S, Thummalapally RR.
europepmc   +1 more source

Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial.

JAMA Psychiatry
Janik A, Qiu X, Lane R, Popova V, Drevets WC, Canuso CM, Macaluso M, Mattingly GW, Shelton RC, Zajecka JM, Fu DJ.   +10 more
europepmc   +1 more source

Blood Concentrations of Folic Acid and Homocysteine Are Associated with Treatment-Resistant Depression Among Female Depressed Patients. [PDF]

Biomolecules
Radoš I, Vuksan-Ćusa Z, Milić J, Šagud M, Lončar Vrančić A, Jakšić N, Vuksan-Ćusa B, Pivac N.   +7 more
europepmc   +1 more source

Spravato for Treatment-Resistant Depression: Efficacy and Sexual Side Effect Profile. [PDF]

Neuropsychiatr Dis Treat
Raza AA, Ahmed GU, Zafar H, Akhtar SO, Bin Mobin M, Samadi A.   +5 more
europepmc   +1 more source

Esketamine Combined With SSRI or SNRI for Treatment-Resistant Depression.

JAMA Psychiatry
Del Casale A, Spirito S, Arena JF, Preissner S, Borro M, Gentile G, Modesti MN, Preissner R, Ferracuti S, Simmaco M.   +9 more
europepmc   +1 more source